A Novel and Cross-Species Active Mammalian INDY (NaCT) Inhibitor Ameliorates Hepatic Steatosis in Mice with Diet-Induced Obesity

Mammalian INDY (mINDY, NaCT, gene symbol SLC13A5) is a potential target for the treatment of metabolically associated fatty liver disease (MAFLD). This study evaluated the effects of a selective, cross-species active, non-competitive, non-substrate-like inhibitor of NaCT. First, the small molecule i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahn, Grit, Willmes, Diana M., El-Agroudy, Nermeen N., Yarnold, Christopher, Jarjes-Pike, Richard, Schaertl, Sabine, Schreiter, Kay, Gehrmann, Wiebke, Wong, Andrea Kuan Cie, Zordan, Tommaso, König, Jörg, Jordan, Jens, Birkenfeld, Andreas L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413491/
https://www.ncbi.nlm.nih.gov/pubmed/36005604
http://dx.doi.org/10.3390/metabo12080732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413491/
https://www.ncbi.nlm.nih.gov/pubmed/36005604
http://dx.doi.org/10.3390/metabo12080732

Ejemplares similares